nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—ocular cancer	0.461	1	CiPCiCtD
Cisplatin—bone cancer—ocular cancer	0.0964	0.396	CtDrD
Cisplatin—germ cell cancer—ocular cancer	0.0765	0.314	CtDrD
Cisplatin—peripheral nervous system neoplasm—ocular cancer	0.0706	0.29	CtDrD
Cisplatin—SLC31A2—Carboplatin—ocular cancer	0.037	0.133	CbGbCtD
Cisplatin—ATP7B—Carboplatin—ocular cancer	0.0268	0.0958	CbGbCtD
Cisplatin—ATP7A—Carboplatin—ocular cancer	0.0268	0.0958	CbGbCtD
Cisplatin—MT2A—Carboplatin—ocular cancer	0.0268	0.0958	CbGbCtD
Cisplatin—MT1A—Carboplatin—ocular cancer	0.0268	0.0958	CbGbCtD
Cisplatin—SOD1—Carboplatin—ocular cancer	0.0213	0.0761	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—ocular cancer	0.0213	0.0761	CbGbCtD
Cisplatin—GSTT1—Carboplatin—ocular cancer	0.0178	0.0637	CbGbCtD
Cisplatin—GSTM1—Carboplatin—ocular cancer	0.0154	0.055	CbGbCtD
Cisplatin—ABCC6—Dactinomycin—ocular cancer	0.0152	0.0544	CbGbCtD
Cisplatin—NQO1—Carboplatin—ocular cancer	0.0122	0.0437	CbGbCtD
Cisplatin—GSTP1—Carboplatin—ocular cancer	0.0111	0.0398	CbGbCtD
Cisplatin—MPO—Carboplatin—ocular cancer	0.00638	0.0229	CbGbCtD
Cisplatin—XDH—Carboplatin—ocular cancer	0.00638	0.0229	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—ocular cancer	0.003	0.0107	CbGbCtD
Cisplatin—ABCC2—Carboplatin—ocular cancer	0.00223	0.00798	CbGbCtD
Cisplatin—ABCG2—Carboplatin—ocular cancer	0.00202	0.00722	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—ocular cancer	0.00108	0.00387	CbGbCtD
Cisplatin—Venous thrombosis—Carboplatin—ocular cancer	0.000647	0.137	CcSEcCtD
Cisplatin—Fluid overload—Carboplatin—ocular cancer	0.000561	0.119	CcSEcCtD
Cisplatin—Extravasation—Carboplatin—ocular cancer	0.0004	0.0847	CcSEcCtD
Cisplatin—Phlebitis—Carboplatin—ocular cancer	0.000294	0.0623	CcSEcCtD
Cisplatin—Myelosuppression—Dactinomycin—ocular cancer	0.000276	0.0585	CcSEcCtD
Cisplatin—Febrile neutropenia—Dactinomycin—ocular cancer	0.000215	0.0456	CcSEcCtD
Cisplatin—Hepatotoxicity—Dactinomycin—ocular cancer	0.000168	0.0355	CcSEcCtD
Cisplatin—Necrosis—Dactinomycin—ocular cancer	0.000165	0.035	CcSEcCtD
Cisplatin—Extravasation—Dactinomycin—ocular cancer	0.000149	0.0314	CcSEcCtD
Cisplatin—Ulcer—Dactinomycin—ocular cancer	0.000137	0.029	CcSEcCtD
Cisplatin—Infection—Carboplatin—ocular cancer	0.000124	0.0262	CcSEcCtD
Cisplatin—Phlebitis—Dactinomycin—ocular cancer	0.000109	0.0231	CcSEcCtD
Cisplatin—Pain—Carboplatin—ocular cancer	0.000107	0.0225	CcSEcCtD
Cisplatin—Body temperature increased—Carboplatin—ocular cancer	9.85e-05	0.0208	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	8.47e-05	0.0179	CcSEcCtD
Cisplatin—Pancytopenia—Dactinomycin—ocular cancer	7.72e-05	0.0163	CcSEcCtD
Cisplatin—Stomatitis—Dactinomycin—ocular cancer	7.07e-05	0.015	CcSEcCtD
Cisplatin—Flushing—Dactinomycin—ocular cancer	6.04e-05	0.0128	CcSEcCtD
Cisplatin—Alopecia—Dactinomycin—ocular cancer	5.75e-05	0.0122	CcSEcCtD
Cisplatin—Erythema—Dactinomycin—ocular cancer	5.67e-05	0.012	CcSEcCtD
Cisplatin—Ill-defined disorder—Dactinomycin—ocular cancer	5.26e-05	0.0111	CcSEcCtD
Cisplatin—Anaemia—Dactinomycin—ocular cancer	5.24e-05	0.0111	CcSEcCtD
Cisplatin—Malaise—Dactinomycin—ocular cancer	5.11e-05	0.0108	CcSEcCtD
Cisplatin—Leukopenia—Dactinomycin—ocular cancer	5.07e-05	0.0107	CcSEcCtD
Cisplatin—Myalgia—Dactinomycin—ocular cancer	4.82e-05	0.0102	CcSEcCtD
Cisplatin—Discomfort—Dactinomycin—ocular cancer	4.77e-05	0.0101	CcSEcCtD
Cisplatin—Oedema—Dactinomycin—ocular cancer	4.62e-05	0.00979	CcSEcCtD
Cisplatin—Infection—Dactinomycin—ocular cancer	4.59e-05	0.00973	CcSEcCtD
Cisplatin—Thrombocytopenia—Dactinomycin—ocular cancer	4.53e-05	0.00958	CcSEcCtD
Cisplatin—Anorexia—Dactinomycin—ocular cancer	4.41e-05	0.00933	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	4.21e-05	0.00892	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—ocular cancer	4.02e-05	0.00851	CcSEcCtD
Cisplatin—Pain—Dactinomycin—ocular cancer	3.95e-05	0.00837	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—ocular cancer	3.81e-05	0.00807	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—ocular cancer	3.66e-05	0.00774	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—ocular cancer	3.41e-05	0.00721	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—ocular cancer	3.32e-05	0.00702	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—ocular cancer	3.16e-05	0.0067	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—EP300—ocular cancer	3.1e-05	0.00277	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TP53—ocular cancer	3.08e-05	0.00275	CbGpPWpGaD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	3.06e-05	0.00273	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—MDM2—ocular cancer	2.94e-05	0.00263	CbGpPWpGaD
Cisplatin—Vomiting—Dactinomycin—ocular cancer	2.94e-05	0.00622	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—CDK6—ocular cancer	2.93e-05	0.00262	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—E2F1—ocular cancer	2.93e-05	0.00262	CbGpPWpGaD
Cisplatin—Rash—Dactinomycin—ocular cancer	2.92e-05	0.00617	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	2.9e-05	0.00259	CbGpPWpGaD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—ocular cancer	2.89e-05	0.00258	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	2.85e-05	0.00254	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PSPH—ocular cancer	2.84e-05	0.00254	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	2.79e-05	0.0025	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDKN2B—ocular cancer	2.79e-05	0.00249	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PSPH—ocular cancer	2.77e-05	0.00247	CbGpPWpGaD
Cisplatin—Nausea—Dactinomycin—ocular cancer	2.75e-05	0.00581	CcSEcCtD
Cisplatin—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	2.72e-05	0.00243	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—MYC—ocular cancer	2.7e-05	0.00241	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TP53—ocular cancer	2.69e-05	0.0024	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—CDKN1B—ocular cancer	2.69e-05	0.0024	CbGpPWpGaD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—ocular cancer	2.64e-05	0.00236	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—AKT1—ocular cancer	2.6e-05	0.00232	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—ocular cancer	2.56e-05	0.00229	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—E2F1—ocular cancer	2.56e-05	0.00228	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CDK2—ocular cancer	2.53e-05	0.00226	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—GNA11—ocular cancer	2.52e-05	0.00226	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—HRAS—ocular cancer	2.49e-05	0.00223	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PSPH—ocular cancer	2.48e-05	0.00222	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—CDKN1A—ocular cancer	2.48e-05	0.00221	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CDK4—ocular cancer	2.39e-05	0.00213	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	2.38e-05	0.00213	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PSPH—ocular cancer	2.38e-05	0.00213	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—EP300—ocular cancer	2.36e-05	0.00211	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—GNAQ—ocular cancer	2.35e-05	0.0021	CbGpPWpGaD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	2.31e-05	0.00207	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDK2—ocular cancer	2.2e-05	0.00197	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—HRAS—ocular cancer	2.12e-05	0.00189	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HDAC1—ocular cancer	2.12e-05	0.00189	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDK4—ocular cancer	2.08e-05	0.00186	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—RB1—ocular cancer	2.08e-05	0.00186	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PSPH—ocular cancer	2.06e-05	0.00184	CbGpPWpGaD
Cisplatin—GSTM1—NRF2 pathway—TGFB1—ocular cancer	2.03e-05	0.00182	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	2.02e-05	0.0018	CbGpPWpGaD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	1.99e-05	0.00178	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	1.98e-05	0.00177	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SAG—ocular cancer	1.88e-05	0.00168	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	1.85e-05	0.00166	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—EIF1AX—ocular cancer	1.83e-05	0.00164	CbGpPWpGaD
Cisplatin—CYP4A11—PPARA activates gene expression—EP300—ocular cancer	1.81e-05	0.00162	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—RB1—ocular cancer	1.81e-05	0.00162	CbGpPWpGaD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	1.77e-05	0.00159	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—MDM2—ocular cancer	1.77e-05	0.00158	CbGpPWpGaD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	1.77e-05	0.00158	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PSPH—ocular cancer	1.75e-05	0.00157	CbGpPWpGaD
Cisplatin—GSTP1—NRF2 pathway—TGFB1—ocular cancer	1.73e-05	0.00155	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	1.71e-05	0.00153	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—ocular cancer	1.69e-05	0.00151	CbGpPWpGaD
Cisplatin—NQO1—NRF2 pathway—TGFB1—ocular cancer	1.69e-05	0.00151	CbGpPWpGaD
Cisplatin—ABCC5—Disease—E2F5—ocular cancer	1.67e-05	0.00149	CbGpPWpGaD
Cisplatin—ABCC5—Disease—E2F4—ocular cancer	1.63e-05	0.00146	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GNA11—ocular cancer	1.63e-05	0.00146	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	1.63e-05	0.00146	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CDKN1B—ocular cancer	1.62e-05	0.00144	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RBL1—ocular cancer	1.6e-05	0.00143	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RPL39—ocular cancer	1.6e-05	0.00143	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	1.6e-05	0.00143	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—E2F1—ocular cancer	1.58e-05	0.00141	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—MDM2—ocular cancer	1.54e-05	0.00138	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GNAQ—ocular cancer	1.52e-05	0.00135	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—CDK2—ocular cancer	1.5e-05	0.00134	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CDKN1A—ocular cancer	1.49e-05	0.00133	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—RPL39—ocular cancer	1.46e-05	0.00131	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	1.45e-05	0.0013	CbGpPWpGaD
Cisplatin—ABCC5—NRF2 pathway—TGFB1—ocular cancer	1.45e-05	0.0013	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HRAS—ocular cancer	1.45e-05	0.00129	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	1.42e-05	0.00127	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—EP300—ocular cancer	1.42e-05	0.00127	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	1.42e-05	0.00127	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDKN1B—ocular cancer	1.41e-05	0.00126	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CDK2—ocular cancer	1.36e-05	0.00122	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PSPH—ocular cancer	1.34e-05	0.0012	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDKN1A—ocular cancer	1.3e-05	0.00116	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TFDP1—ocular cancer	1.29e-05	0.00115	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CDK4—ocular cancer	1.29e-05	0.00115	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—TGFB1—ocular cancer	1.26e-05	0.00112	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	1.25e-05	0.00112	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—EP300—ocular cancer	1.24e-05	0.00111	CbGpPWpGaD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	1.22e-05	0.00109	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PSPH—ocular cancer	1.21e-05	0.00108	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PSPH—ocular cancer	1.2e-05	0.00107	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	1.17e-05	0.00105	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CDKN1B—ocular cancer	1.15e-05	0.00102	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—RB1—ocular cancer	1.12e-05	0.001	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	1.11e-05	0.000996	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CCND1—ocular cancer	1.09e-05	0.000976	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	1.08e-05	0.000961	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—TGFB1—ocular cancer	1.07e-05	0.000955	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CDKN1A—ocular cancer	1.06e-05	0.000945	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GNA11—ocular cancer	1.05e-05	0.000939	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAML2—ocular cancer	1.02e-05	0.000915	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—ocular cancer	1.02e-05	0.000908	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—EP300—ocular cancer	1.01e-05	0.000899	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—AKT1—ocular cancer	9.89e-06	0.000884	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GNAQ—ocular cancer	9.77e-06	0.000873	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	9.66e-06	0.000864	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	9.56e-06	0.000855	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	9.28e-06	0.000829	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PSPH—ocular cancer	9.22e-06	0.000824	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—MDM2—ocular cancer	9.1e-06	0.000814	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GNA11—ocular cancer	8.93e-06	0.000798	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—ocular cancer	8.86e-06	0.000792	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PSPH—ocular cancer	8.86e-06	0.000792	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	8.77e-06	0.000784	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	8.76e-06	0.000783	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	8.73e-06	0.00078	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GNA11—ocular cancer	8.7e-06	0.000778	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	8.65e-06	0.000773	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MDM2—ocular cancer	8.62e-06	0.00077	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFB1—ocular cancer	8.47e-06	0.000757	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—EP300—ocular cancer	8.44e-06	0.000754	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	8.33e-06	0.000744	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	8.31e-06	0.000743	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GNAQ—ocular cancer	8.3e-06	0.000742	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	8.13e-06	0.000727	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GNAQ—ocular cancer	8.09e-06	0.000723	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CDKN1B—ocular cancer	7.87e-06	0.000703	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GNA11—ocular cancer	7.81e-06	0.000698	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	7.63e-06	0.000682	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HDAC1—ocular cancer	7.49e-06	0.000669	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GNA11—ocular cancer	7.49e-06	0.000669	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TGFB1—ocular cancer	7.33e-06	0.000655	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SAG—ocular cancer	7.29e-06	0.000652	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CDKN1A—ocular cancer	7.26e-06	0.000649	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GNAQ—ocular cancer	7.26e-06	0.000649	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—MDM2—ocular cancer	6.98e-06	0.000623	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GNAQ—ocular cancer	6.96e-06	0.000622	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EP300—ocular cancer	6.91e-06	0.000617	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	6.88e-06	0.000615	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN2B—ocular cancer	6.71e-06	0.0006	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MYC—ocular cancer	6.68e-06	0.000597	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	6.66e-06	0.000595	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	6.58e-06	0.000588	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PSPH—ocular cancer	6.54e-06	0.000584	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	6.51e-06	0.000582	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	6.5e-06	0.000581	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GNA11—ocular cancer	6.49e-06	0.00058	CbGpPWpGaD
Cisplatin—PTGS2—Disease—E2F5—ocular cancer	6.46e-06	0.000577	CbGpPWpGaD
Cisplatin—PTGS2—Disease—E2F4—ocular cancer	6.32e-06	0.000565	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MDM2—ocular cancer	6.23e-06	0.000557	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	6.22e-06	0.000556	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RBL1—ocular cancer	6.2e-06	0.000554	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RPL39—ocular cancer	6.2e-06	0.000554	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PSPH—ocular cancer	6.11e-06	0.000546	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—ocular cancer	6.04e-06	0.000539	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GNAQ—ocular cancer	6.03e-06	0.000539	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	5.94e-06	0.000531	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—ocular cancer	5.77e-06	0.000516	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	5.66e-06	0.000506	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GNA11—ocular cancer	5.52e-06	0.000493	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—ocular cancer	5.48e-06	0.00049	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	5.48e-06	0.00049	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—EP300—ocular cancer	5.45e-06	0.000487	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	5.23e-06	0.000467	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	5.21e-06	0.000466	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GNAQ—ocular cancer	5.13e-06	0.000458	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—AKT1—ocular cancer	5.1e-06	0.000456	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TFDP1—ocular cancer	5e-06	0.000447	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—ocular cancer	5e-06	0.000446	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.87e-06	0.000435	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—ocular cancer	4.73e-06	0.000422	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	4.61e-06	0.000412	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	4.54e-06	0.000406	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	4.53e-06	0.000405	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	4.46e-06	0.000399	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNA11—ocular cancer	4.22e-06	0.000377	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	4.21e-06	0.000376	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—ocular cancer	4.17e-06	0.000373	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.14e-06	0.00037	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	4.01e-06	0.000359	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAML2—ocular cancer	3.97e-06	0.000355	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GNAQ—ocular cancer	3.92e-06	0.00035	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	3.88e-06	0.000347	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—ocular cancer	3.83e-06	0.000342	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNA11—ocular cancer	3.8e-06	0.00034	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNA11—ocular cancer	3.77e-06	0.000336	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	3.73e-06	0.000333	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MDM2—ocular cancer	3.72e-06	0.000333	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	3.7e-06	0.00033	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GNAQ—ocular cancer	3.54e-06	0.000316	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—EP300—ocular cancer	3.51e-06	0.000314	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GNAQ—ocular cancer	3.5e-06	0.000313	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—ocular cancer	3.42e-06	0.000306	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1B—ocular cancer	3.4e-06	0.000304	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—ocular cancer	3.29e-06	0.000294	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	3.22e-06	0.000288	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	3.21e-06	0.000287	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.16e-06	0.000283	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	3.15e-06	0.000282	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1A—ocular cancer	3.14e-06	0.00028	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EP300—ocular cancer	2.99e-06	0.000267	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—EP300—ocular cancer	2.98e-06	0.000267	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—EP300—ocular cancer	2.91e-06	0.00026	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HDAC1—ocular cancer	2.9e-06	0.000259	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNA11—ocular cancer	2.9e-06	0.000259	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNA11—ocular cancer	2.79e-06	0.000249	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GNAQ—ocular cancer	2.7e-06	0.000241	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	2.64e-06	0.000236	CbGpPWpGaD
Cisplatin—XDH—Metabolism—EP300—ocular cancer	2.61e-06	0.000233	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN2B—ocular cancer	2.6e-06	0.000233	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—ocular cancer	2.6e-06	0.000233	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—ocular cancer	2.6e-06	0.000232	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GNAQ—ocular cancer	2.59e-06	0.000232	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—EP300—ocular cancer	2.5e-06	0.000223	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	2.23e-06	0.0002	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.18e-06	0.000195	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—ocular cancer	2.17e-06	0.000194	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—ocular cancer	2.12e-06	0.00019	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNA11—ocular cancer	2.06e-06	0.000184	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—ocular cancer	2.04e-06	0.000183	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNA11—ocular cancer	1.92e-06	0.000172	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GNAQ—ocular cancer	1.91e-06	0.000171	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—ocular cancer	1.84e-06	0.000165	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—ocular cancer	1.8e-06	0.000161	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—ocular cancer	1.8e-06	0.000161	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GNAQ—ocular cancer	1.79e-06	0.00016	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—ocular cancer	1.76e-06	0.000157	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—ocular cancer	1.58e-06	0.000141	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—ocular cancer	1.51e-06	0.000135	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—ocular cancer	1.44e-06	0.000129	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.44e-06	0.000129	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—ocular cancer	1.41e-06	0.000126	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—ocular cancer	1.32e-06	0.000118	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—ocular cancer	1.31e-06	0.000117	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—ocular cancer	1.27e-06	0.000114	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—ocular cancer	1.26e-06	0.000112	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—ocular cancer	1.22e-06	0.000109	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—ocular cancer	1.16e-06	0.000103	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—ocular cancer	1.11e-06	9.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—ocular cancer	1.01e-06	9.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—ocular cancer	1.01e-06	8.99e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—ocular cancer	9.69e-07	8.66e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—ocular cancer	9.32e-07	8.33e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—ocular cancer	8.51e-07	7.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—ocular cancer	7.92e-07	7.08e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—ocular cancer	7.68e-07	6.86e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—ocular cancer	7.6e-07	6.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—ocular cancer	7e-07	6.25e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—ocular cancer	6.87e-07	6.14e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—ocular cancer	6.42e-07	5.74e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—ocular cancer	5.86e-07	5.24e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—ocular cancer	5.63e-07	5.03e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—ocular cancer	4.15e-07	3.71e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—ocular cancer	3.88e-07	3.47e-05	CbGpPWpGaD
